VIVO CAPITAL, LLC

AUM: $5.42 B
13-F Portfolio Value: $1.22 B
Last 13-F Filed: Q4 2023
Concentration in top 10: 72.94%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
ACRSAclaris Therapeutics, Inc.-898,631Exited13F
AMRSQAmyris, Inc-7,750,828Exited13F
ACLXArcellx Inc.-503,565Exited13F
ASLNAslan Pharmaceuticals Ltd-568,182Exited13F
BCABBioAtla Inc-534,181Exited13F
CLNNClene Inc-2,645,338Exited13F
FULCFulcrum Therapeutics Inc-520,000Exited13F
GTHGenetron Holdings Ltd-8,124,174Exited13F
IMPLImpel NeuroPharma Inc-2,884,789Exited13F
TILInstil Bio Inc-12,486,787Exited13F
VTYXVentyx Biosciences Inc-422,075Exited13F
SVASinovac Biotech Ltd.-5,900,000Exited13F